1) Alpelisib, Novartis Alpelisib (BYL719, NVP-BYL719) is an alpha isoform-specific inhibitor of phosphoinositide 3-kinase (Pi3K) that is being investigated as...
Read More...
The post The ten most promising cancer drugs being trialled appeared first on Pharmaceutical Technology.
Original Article: The ten most promising cancer drugs being trialled